As of Thursday, February 12, Neuronetics, Inc.’s STIM share price has dipped by 8.89%, which has investors questioning if this is right time to buy.
As of Wednesday, February 11, Neuronetics, Inc.’s STIM share price has surged by 21.58%, which has investors questioning if this is right time to sell.
Inspire Medical Systems, Inc. is a Sell due to competitive pressures, reimbursement uncertainties & margin compression. Read ...
Empower BP is a landmark global pivotal study evaluating the safety and effectivenessof the implantable ARC-IM® Systemto ...
Donoghue was awarded the prize, considered among the most prestigious honors in engineering, for pioneering work in ...
Discover how Electroencephalography (EEG) records brain activity to diagnose epilepsy, strokes, and sleep disorders. Learn ...
DUSQ has rebranded from InnerGize to reflect its pivot toward wearables designed for sleep regulation and recovery optimisation ...
Researchers at the company are trying to understand their A.I. system’s mind—examining its neurons, running it through ...
SetPoint Medical today announced the first patients in Chicago have been treated with the SetPoint System, an FDA-approved ...
Nexstim Plc ("Nexstim" or "Company") has received an order for an NBS System 5 through a distributor in India. The end customer has an earlier generation Nexstim system. Nexstim gained an import ...
In the wake of a Central Florida couple suing a Longwood fertility clinic for implanting the wrong embryo, legal experts say ...
For most people, cold weather is an inconvenience, requiring an extra layer of clothing or the thermostat to be turned up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results